Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:106–116
Jonas JB, Cheung CM, Panda-Jonas S (2017) Updates on the epidemiology of age-related macular degeneration. Asia-Pac J Ophthalmol 6:493–497
Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147–1159
Thomas CJ, Mirza RG, Gill MK (2021) Age-Related Macular Degeneration. Med Clin North Am 105:473–491
Myers CE, Klein BE, Gangnon R, Sivakumaran TA, Iyengar SK, Klein R (2014) Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 121:1949–1955
Seddon JM, Cote J, Davis N, Rosner B (2003) Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121:785–792
Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008) Dietary ω-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126:826–833
Tisdale AK, Agrón E, Sunshine SB, Clemons TE, Ferris FL 3rd, Chew EY, Age-Related Eye Disease Study Research Group (2019) Association of dietary and supplementary calcium intake with age-related macular degeneration: age-related eye disease study report 39. JAMA Ophthalmol 137(5):543–550. https://doi.org/10.1001/jamaophthalmol.2019.0292
Merle BM, Silver RE, Rosner B, Seddon JM (2017) Associations between vitamin D intake and progression to incident advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 58:4569–4578
Article CAS PubMed PubMed Central Google Scholar
Millen AE, Nie J, Mares JA, Lutsey PL, LaMonte MJ, Meuer SM, Sahli MW, Andrews CA, Klein BE, Klein R (2019) Serum 25-hydroxyvitamin D concentrations and incidence of age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Invest Ophthalmol Vis Sci 60:1362–1371
Article CAS PubMed PubMed Central Google Scholar
Seddon JM, Cote J, Davis N, Rosner B (2003) Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121:785–792
McGuinness MB, Le J, Mitchell P, Gopinath B, Cerin E, Saksens NT, Schick T, Hoyng CB, Guymer RH, Finger RP (2017) Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol 180:29–38
Heesterbeek TJ, Lorés-Motta L, Hoyng CB, Lechanteur YT, den Hollander AI (2020) Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt 40:140–170
Article PubMed PubMed Central Google Scholar
Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112:533–539
Fleckenstein M, Keenan TD, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY (2021) Age-related macular degeneration. Nat Rev Dis Primers 7:1–25
Ferris III FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR, Beckman Initiative for Macular Research Classification Committee (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844-851
Schmitz-Valckenberg S, Sadda S, Staurenghi G, Chew EY, Fleckenstein M, Holz FG (2016) “Geographic atrophy”: semantic considerations and literature review. Retina (Philadelphia, Pa.) 36:2250
Fleckenstein M, Mitchell P, Freund KB, Sadda S, Holz FG, Brittain C, Henry EC, Ferrara D (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125:369–390
Gune S, Abdelfattah NS, Karamat A, Balasubramanian S, Marion KM, Morgenthien E, Sadda SR (2020) Spectral-domain OCT–based prevalence and progression of macular atrophy in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 127:523–532
Sadda SR, Abdelfattah NS, Lei J, Shi Y, Marion KM, Morgenthien E, Gune S, Balasubramanian S (2020) Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 127:1360–1370
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA (2021) C5 inhibitor Avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial. Ophthalmology 128:576–586
Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, Nuernberg P (2020) Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology 127:186–195
Seddon JM (2017) Macular degeneration epidemiology: Nature-Nurture, lifestyle factors, genetic risk, and gene-environment interactions–the Weisenfeld Award Lecture. Invest Ophthalmol Vis Sci 58:6513–6528
Article CAS PubMed PubMed Central Google Scholar
Kuan V, Warwick A, Hingorani A, Tufail A, Cipriani V, Burgess S, Sofat R, Fritsche LG, Igl W, Bailey JN, Grassmann F (2021) Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study. JAMA Ophthalmol
Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276:1141–1146
Article CAS PubMed Google Scholar
Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057–2060
Article CAS PubMed Google Scholar
Chew EY, Clemons TE, Agrón E, Sperduto RD, SanGiovanni JP, Kurinij N, Davis MD (2013) Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology 120:1604–1611
Cougnard-Gregoire A, Delyfer MN, Korobelnik JF, Rougier MB, Le Goff M, Dartigues JF, Barberger-Gateau P, Delcourt C (2014) Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study. PLoS One 9:90973
Curcio CA, Johnson M, Rudolf M, Huang JD (2011) The oil spill in ageing Bruch membrane. Br J Ophthalmol 95:1638–1645
Curcio CA, Johnson M, Huang JD, Rudolf M (2010) Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 51:451–467
Article CAS PubMed PubMed Central Google Scholar
Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA (2010) Abundant lipid and protein components of drusen. PLoS One 5:10329
Thakkinstian A, Bowe S, McEvoy M, Smith W, Attia J (2006) Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 164:813–822
Gehlbach P, Li T, Hatef E (2016) Statins for age‐related macular degeneration. Cochrane Database of Systematic Reviews
Wu T, Fujihara M, Tian J, Jovanovic M, Grayson C, Cano M, Gehlbach P, Margaron P, Handa JT (2010) Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels. J Neurochem 114:1734–1744
Article CAS PubMed PubMed Central Google Scholar
Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris III FL, Chew EY, Study TA, Group R (2015) The association of statin use with age-related macular degeneration progression: The age-related eye disease study 2 report number 9. Ophthalmology 122:2490-2496
Guymer RH, Chiu AW, Lim L, Baird PN (2005) HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Surv Ophthalmol 50:194–206
Guymer RH, Baird PN, Varsamidis M, Busija L, Dimitrov PN, Aung KZ, Makeyeva GA, Richardson AJ, Lim L, Robman LD (2013) Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. PLoS One 8:83759
Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN (2001) Risk of macular degeneration in users of statins: cross sectional study. BMJ 323:375–376
Article CAS PubMed PubMed Central Google Scholar
Klein R, Klein BE, Tomany SC, Danforth LG, Cruickshanks KJ (2003) Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 121:1151–1155
Article CAS PubMed Google Scholar
McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR (2001) Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust 175:340
Article CAS PubMed Google Scholar
Klein R, Knudtson MD, Klein BE (2007) Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 144:1–6
VanderBeek BL, Zacks DN, Talwar N, Nan B, Stein JD (2013) Role of statins in the development and progression of age-related macular degeneration. Retina 33:414
Article CAS PubMed PubMed Central Google Scholar
Vavvas DG, Daniels AB, Kapsala ZG, Goldfarb JW, Ganotakis E, Loewenstein JI, Young LH, Gragoudas ES, Eliott D, Kim IK, Tsilimbaris MK (2016) Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment. EBioMedicine 5:198–203
留言 (0)